Back to today’s briefing

Story perspectives

Stanford Breakthrough: New Molecule Targets Drug-Resistant Cancer Cells

5/24/2025

38 5

Summary

Story summary

A revolutionary molecule created by researchers at Stanford University and Penn State is making waves in cancer treatment by triggering self-destruction in cancer cells. By targeting crucial proteins like BCL6, this promising method shows potential against drug-resistant cancers, aiming to protect healthy cells and paving the way for human trials in just two years.

1 of 1

Story summary

A revolutionary molecule created by researchers at Stanford University and Penn State is making waves in cancer treatment by triggering self-destruction in cancer cells. By targeting crucial proteins like BCL6, this promising method shows potential against drug-resistant cancers, aiming to protect healthy cells and paving the way for human trials in just two years.